You need to enroll in this course to view this chapter
Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting. A Real-World Evidence Review of CAPLA 1000+ and MAYARI Trial
0% Course Complete
Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting. A Real-World Evidence Review of CAPLA 1000+ and MAYARI Trial Attachments
100%
Page 1 of ?/?
Go to:
Loading PDF...